Episode 7

Avencia Sánchez-Mejías, Integra Therapeutics

Published on: 13th November, 2025

Biotech leader Avencia Sánchez-Mejías, CEO of Integra Therapeutics, joins A Call to Lead to share her leadership and entrepreneurship story, as well as her take on innovation in Europe’s fast-rising life sciences ecosystem.

In this episode of A Call To Lead, Avencia shares lessons on resilience, uncertainty, diversity, and the human side of leadership in science-driven entrepreneurship. Listen to her journey from academia to biotech CEO, her vision for safer gene editing, and how resilient leadership is reshaping European biotechnology.

Next Episode All Episodes Previous Episode

Listen for free

Show artwork for A Call to Lead @LifeScience ORG

About the Podcast

A Call to Lead @LifeScience ORG
Sharing the leadership journeys of life science entrepreneurs shaping the future of healthcare.
A Call To Lead is a series shining a light on the leadership, vision, and impact of European life science CEOs who are proving that world-class ventures don’t need to be built in Boston to shape the future of healthcare.

Each episode features a one-on-one conversation with a European life science CEO and member of the LifeScience ORG community. Our conversations are not about companies or pipelines; instead, guests reflect on their personal journeys, the pivotal choices that shaped their careers, and the future they are helping to build. These kinds of insights are rarely shared publicly.

New episodes are released every Thursday.